15621213|t|Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
15621213|a|Degeneration of nigrostriatal dopamine neurons and cholinergic cortical neurones are the main pathological features of Parkinson's disease (PD) and for the cognitive deficit in dementia of the Alzheimer' type (AD) and in dementia with Lewy bodies (DLB), respectively. Many PD and DLB subjects have dementia and depression resulting from possible degeneration of cholinergic and noradrenergic and serotonergic neurons. On the other hand, AD patients may also develop extrapyramidal features as well as depression. In both PD and AD there is, respectively, accumulation of iron within the melanin containing dopamine neurons of pars compacta and with in the plaques and tangle. It has been suggested that iron accumulation may contribute to the oxidative stress induced apoptosis reported in both diseases. This may result from increased glia hydrogen peroxide producing monoamine oxidase (MAO) activity that can generate of reactive hydroxyl radical formed from interaction of iron and hydrogen peroxide. We have therefore prepared a series of novel bifunctional drugs from the neuroprotective-antiapoptotic antiparkinson monoamine oxidase B inhibitor, rasagiline, by introducing a carbamate cholinesterase (ChE) inhibitory moiety into it. Ladostigil (TV-3326, N-propargyl-3R-aminoindan-5yl)-ethyl methylcarbamate), has both ChE and MAO-AB inhibitory activity, as potential treatment of AD and DLB or PD subjects with dementia Being a brain selective MAO-AB inhibitor it has limited potentiation of the pressor response to oral tyramine and exhibits antidepressant activity similar to classical non-selective MAO inhibitor antidepressants by increasing brain serotonin and noradrenaline. Ladostigil inhibits brain acetyl and butyrylcholinesterase in rats and antagonizes scopolamine-induced inhibition of spatial learning. Ladostigil like MAO-B inhibitor it prevents MPTP Parkinsonism in mice model and retains the in vitro and in vivo neuroprotective activity of rasagiline. Ladostigil, rasagiline and other propargylamines have been demonstrated to have neuroprotective activity in several in vitro and in vivo models, which have been shown be associated with propargylamines moiety, since propargylamines itself possess these properties. The mechanism of neuroprotective activity has been attributed to the ability of propargylamines-inducing the antiapoptotic family proteins Bcl-2 and Bcl-xl, while decreasing Bad and Bax and preventing opening of mitochondrial permeability transition pore. Iron accumulates in brain regions associated with neurodegenerative diseases of PD, AD, amyotrophic lateral sclerosis and Huntington disease. It is thought to be involved in Fenton chemistry oxidative stress observed in these diseases. The neuroprotective activity of propargylamines led us to develop several novel bifunctional iron chelator from our prototype brain permeable iron chelators, VK-28, possessing propargylamine moiety (HLA-20, M30 and M30A) to iron out iron from the brain. These compounds have been shown to have iron chelating and monoamine oxidase A and B selective brain inhibitory and neuroprotective-antiapoptotic actions.
15621213	33	38	MAO-B	Gene	4129
15621213	49	59	rasagiline	Chemical	MESH:C031967
15621213	64	68	iron	Chemical	MESH:D007501
15621213	78	83	VK-28	Chemical	-
15621213	129	141	brain ageing	Disease	MESH:D001927
15621213	153	179	neurodegenerative diseases	Disease	MESH:D019636
15621213	211	219	dopamine	Chemical	MESH:D004298
15621213	300	319	Parkinson's disease	Disease	MESH:D010300
15621213	321	323	PD	Disease	MESH:D010300
15621213	337	354	cognitive deficit	Disease	MESH:D003072
15621213	358	389	dementia of the Alzheimer' type	Disease	MESH:D000544
15621213	391	393	AD	Disease	MESH:D000544
15621213	402	427	dementia with Lewy bodies	Disease	MESH:D020961
15621213	429	432	DLB	Disease	MESH:D020961
15621213	454	456	PD	Disease	MESH:D010300
15621213	461	464	DLB	Disease	MESH:D020961
15621213	479	487	dementia	Disease	MESH:D003704
15621213	492	502	depression	Disease	MESH:D003866
15621213	618	620	AD	Disease	MESH:D000544
15621213	621	629	patients	Species	9606
15621213	647	670	extrapyramidal features	Disease	MESH:D001480
15621213	682	692	depression	Disease	MESH:D003866
15621213	702	704	PD	Disease	MESH:D010300
15621213	709	711	AD	Disease	MESH:D000544
15621213	752	756	iron	Chemical	MESH:D007501
15621213	768	775	melanin	Chemical	MESH:D008543
15621213	787	795	dopamine	Chemical	MESH:D004298
15621213	884	888	iron	Chemical	MESH:D007501
15621213	1022	1039	hydrogen peroxide	Chemical	MESH:D006861
15621213	1104	1129	reactive hydroxyl radical	Chemical	-
15621213	1157	1161	iron	Chemical	MESH:D007501
15621213	1166	1183	hydrogen peroxide	Chemical	MESH:D006861
15621213	1302	1321	monoamine oxidase B	Gene	4129
15621213	1333	1343	rasagiline	Chemical	MESH:C031967
15621213	1420	1430	Ladostigil	Chemical	MESH:C423264
15621213	1432	1439	TV-3326	Chemical	MESH:C423264
15621213	1441	1493	N-propargyl-3R-aminoindan-5yl)-ethyl methylcarbamate	Chemical	MESH:C423264
15621213	1567	1569	AD	Disease	MESH:D000544
15621213	1574	1577	DLB	Disease	MESH:D020961
15621213	1581	1583	PD	Disease	MESH:D010300
15621213	1598	1606	dementia	Disease	MESH:D003704
15621213	1708	1716	tyramine	Chemical	MESH:D014439
15621213	1839	1848	serotonin	Chemical	MESH:D012701
15621213	1853	1866	noradrenaline	Chemical	MESH:D009638
15621213	1868	1878	Ladostigil	Chemical	MESH:C423264
15621213	1894	1926	acetyl and butyrylcholinesterase	Gene	65036
15621213	1930	1934	rats	Species	10116
15621213	1951	1962	scopolamine	Chemical	MESH:D012601
15621213	2003	2013	Ladostigil	Chemical	MESH:C423264
15621213	2019	2024	MAO-B	Gene	25750
15621213	2047	2051	MPTP	Chemical	MESH:D015632
15621213	2052	2064	Parkinsonism	Disease	MESH:D010302
15621213	2068	2072	mice	Species	10090
15621213	2144	2154	rasagiline	Chemical	MESH:C031967
15621213	2156	2166	Ladostigil	Chemical	MESH:C423264
15621213	2168	2178	rasagiline	Chemical	MESH:C031967
15621213	2189	2204	propargylamines	Chemical	MESH:C009054
15621213	2342	2357	propargylamines	Chemical	MESH:C009054
15621213	2372	2387	propargylamines	Chemical	MESH:C009054
15621213	2501	2516	propargylamines	Chemical	MESH:C009054
15621213	2560	2565	Bcl-2	Gene	24224
15621213	2570	2576	Bcl-xl	Gene	598
15621213	2603	2606	Bax	Gene	581
15621213	2677	2681	Iron	Chemical	MESH:D007501
15621213	2727	2753	neurodegenerative diseases	Disease	MESH:D019636
15621213	2757	2759	PD	Disease	MESH:D010300
15621213	2761	2763	AD	Disease	MESH:D000544
15621213	2765	2794	amyotrophic lateral sclerosis	Disease	MESH:D000690
15621213	2799	2817	Huntington disease	Disease	MESH:D006816
15621213	2945	2960	propargylamines	Chemical	MESH:C009054
15621213	3006	3010	iron	Chemical	MESH:D007501
15621213	3055	3059	iron	Chemical	MESH:D007501
15621213	3071	3076	VK-28	Chemical	-
15621213	3089	3103	propargylamine	Chemical	MESH:C009054
15621213	3120	3123	M30	ProteinMutation	tmVar:p|Allele|M|30;VariantGroup:0;CorrespondingGene:4129;CorrespondingSpecies:9606
15621213	3128	3132	M30A	ProteinMutation	tmVar:p|SUB|M|30|A;HGVS:p.M30A;VariantGroup:0;CorrespondingGene:4129;CorrespondingSpecies:9606
15621213	3137	3141	iron	Chemical	MESH:D007501
15621213	3146	3150	iron	Chemical	MESH:D007501
15621213	3207	3211	iron	Chemical	MESH:D007501
15621213	3226	3251	monoamine oxidase A and B	Gene	4128;4129
15621213	Association	MESH:D000690	CorrespondingGene:4129;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
15621213	Negative_Correlation	MESH:C423264	MESH:D015632
15621213	Association	MESH:C009054	581
15621213	Association	MESH:C009054	4128
15621213	Negative_Correlation	MESH:C031967	MESH:D001927
15621213	Association	MESH:D006816	4128
15621213	Association	MESH:D006816	HGVS:p.M30A;CorrespondingGene:4129
15621213	Association	MESH:D004298	MESH:D020961
15621213	Negative_Correlation	MESH:C423264	MESH:D010302
15621213	Association	MESH:D006816	CorrespondingGene:4129;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
15621213	Association	MESH:D004298	MESH:D010300
15621213	Association	MESH:C009054	MESH:D000690
15621213	Association	MESH:C009054	MESH:D006816
15621213	Negative_Correlation	MESH:C423264	MESH:D020961
15621213	Negative_Correlation	MESH:C423264	MESH:D003704
15621213	Association	MESH:C009054	HGVS:p.M30A;CorrespondingGene:4129
15621213	Association	MESH:C009054	CorrespondingGene:4129;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
15621213	Positive_Correlation	MESH:D007501	MESH:D000544
15621213	Positive_Correlation	MESH:D007501	MESH:D010300
15621213	Association	MESH:D004298	MESH:D007501
15621213	Association	MESH:D004298	MESH:D003072
15621213	Association	MESH:D007501	MESH:D008543
15621213	Association	MESH:C009054	24224
15621213	Negative_Correlation	MESH:C031967	MESH:D019636
15621213	Association	MESH:D001927	4129
15621213	Association	MESH:D007501	MESH:D019636
15621213	Comparison	MESH:C031967	MESH:C423264
15621213	Negative_Correlation	MESH:C423264	MESH:D012601
15621213	Negative_Correlation	MESH:C031967	4129
15621213	Association	MESH:D007501	MESH:D001927
15621213	Association	MESH:D000690	HGVS:p.M30A;CorrespondingGene:4129
15621213	Positive_Correlation	MESH:D015632	MESH:D010302
15621213	Association	MESH:D000690	4128
15621213	Negative_Correlation	MESH:C423264	MESH:D000544
15621213	Negative_Correlation	MESH:C423264	25750
15621213	Association	MESH:D004298	MESH:D008543
15621213	Association	MESH:D006861	MESH:D007501
15621213	Negative_Correlation	MESH:C423264	65036
15621213	Association	MESH:C009054	598
15621213	Negative_Correlation	MESH:C423264	MESH:D010300
15621213	Association	MESH:D000690	4129
15621213	Association	MESH:D006816	4129

